Aplastic Anemia

ASH 2024 Research Summaries (Aplastic Anemia and PNH)

Graphic for 2024 ASH Summary for Patients on Aplastic Anemia and P-N-H

This publication offers summaries of selected abstracts presented at the Annual Meeting of the American Hematology Society held in December 2024. It provides new and updated information about research into the diagnosis…

Health Equity for Non Transplant Treatment Panel Discussion

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Eileen Hu, MD, PhD
Yazan F. Madanat, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…

Health Equity for Aplastic Anemia, MDS, and AML Transplantation Panel Discussion

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Myelodysplastic Syndromes (MDS)
Presenter(s)
Julio Alvarenga Thiebaud, MD.
Clayton Jackson, MD
Addresses the barriers of ageism, geographic and cultural challenges, delays in diagnosis, limited English proficiency, financial toxicity, and long-term supportive care in pathophysiology, diagnosis, and clinical management of bone marrow failure diseases. For more content like…

“My labs didn’t tell the whole story” Jen’s Aplastic Anemia Journey

Jen had a great life. She was married with two children, and she’s just transitioned from teaching to school counseling. At 41, life was busy yet wonderful.

Her symptoms were unusual, but not alarming. The leg pain was new, as was the bruising. Then fatigue set in, far beyond usual tiredness from her schedule. A visit to the doctor did not offer a definitive diagnosis.  They suggested it was her condition with Hashimoto's thyroiditis, but with the new bruising, they ordered labs. It was February 2022.

ASH 2025 Updates: Aplastic Anemia and PNH Webinar

Thumbnail for video Watch Now

Topic(s)
Aplastic Anemia
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter(s)
Taha Bat, MD
In this webinar, Dr. Taha Bat discusses research most relevant to patients reported over the past year on the biology and treatment for Aplastic Anemia and PNH. The studies were presented at the American Society of Hematology (ASH) 2025 meeting. These findings will be explained…

Understanding Clinical Trials

Fact Sheet - Understanding Clinical Trials

This guide provides information about clinical trials and gives you some things to consider when deciding whether to take part

What is Biosimilar?

Fact Sheet - Biosimilar

A Biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication)

Subscribe to Aplastic Anemia

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.